Design, synthesis, and preliminary biological evaluation of 3′,4′,5′-trimethoxy flavonoid salicylate derivatives as potential anti-tumor agents
Authors:
- 21 December 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 43 (4) , 1874-1884
Abstract
According to the pharmacophore combination principle, a set of new 3′,4′,5′-trimethoxy flavonoid salicylate derivatives were designed, synthesized, and evaluated for biological activity. The cytotoxicity evaluation revealed that compound 10v exhibited higher potency than 5-Fu against HCT-116 cells. Preliminary biological activity studies showed that compound 10v could inhibit the colony formation and migration of HCT-116 cells. Besides, the Hoechst 33258 staining assay and flow cytometry revealed that treatment with compound 10v induced the apoptosis of HCT-116 cells in a concentration-dependent manner, while it had no effect on their cell cycle. The WB analysis suggested that HIF-1α, tubulin, HK-2, and PFK might be the potential pharmacophore targets of compound 10v. Tubulin was a potential drug target for compound 10v, which was explained by analyzing the crystal structure of compound 10v complexed with tubulin. These results indicated that compound 10v might be a promising anti-tumor agent candidate, deserving further optimization and evaluation.Keywords
Funding Information
- Education Department of Hunan Province (17K082, 16K079)
This publication has 39 references indexed in Scilit:
- Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular CarcinomaPLOS ONE, 2013
- Recent agents targeting HIF‐1α for cancer therapyJournal of Cellular Biochemistry, 2013
- Tumor vasculature as target for therapeutic interventionExpert Opinion on Investigational Drugs, 2010
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementThe Lancet Oncology, 2009
- Methylalpinumisoflavone Inhibits Hypoxia-inducible Factor-1 (HIF-1) Activation by Simultaneously Targeting Multiple PathwaysJournal of Biological Chemistry, 2009
- Flavonoids induce HIF-1α but impair its nuclear accumulation and activityFree Radical Biology and Medicine, 2008
- Inhibition of HIF‐1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3‐M cellsMolecular Carcinogenesis, 2008
- Flavopiridol, An Inhibitor of Transcription: Implications, Problems and SolutionsCell Cycle, 2004
- Flavonoids: Promising anticancer agentsMedicinal Research Reviews, 2003
- Cancer Cell CyclesScience, 1996